SANDOZ FESOTERODINE FUMARATE
SANDOZ CANADA INCORPORATED
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of SANDOZ FESOTERODINE FUMARATE in Canada?
Yes. SANDOZ FESOTERODINE FUMARATE 8MG has an active shortage reported to Health Canada (last updated September 8, 2026).
Why is SANDOZ FESOTERODINE FUMARATE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will SANDOZ FESOTERODINE FUMARATE be available again?
The estimated resolution date (September 18, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
TOVIAZ
PFIZER CANADA ULC
ACH-FESOTERODINE
ACCORD HEALTHCARE INC
Other Products
APO-FESOTERODINE
APOTEX INC
SANDOZ FESOTERODINE FUMARATE
SANDOZ CANADA INCORPORATED
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
Sandoz Fesoterodine Fumarate 8 mg tablet
Sandoz Fesoterodine Fumarate 8 mg tablet; Out of specification (Diester impurity)
Moderate health risk
Possible match — not confirmed
SANDOZ FESOTERODINE FUMARATE
SANDOZ FESOTERODINE FUMARATE: The Diester impurity is out of specification in the affected lot(s)
Moderate health risk
Possible match — not confirmed
Sandoz Fesoterodine Fumarate 8 mg tablet
Sandoz Fesoterodine Fumarate 8 mg tablet; Out-of-specification (diester impurity)
Moderate health risk
Possible match — not confirmed
DIN
02521776
Strength
8MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495910
DIN 02495937
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759